R&D | February 24, 2026
Promise Bio launches frontier Epiproteomic Innovation Grant to supercharge biotech R&D
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
Each company will share operational data with Evinova, feeding the platform’s AI engines to provide benchmarks and actionable insights, aiming to speed up trials while maintaining top-tier patient care
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
Gefion, powered entirely by renewable energy, boasts more than 1,500 NVIDIA GPUs
The funding will accelerate Sinopia’s data-driven drug discovery efforts
The state-of-the-art facility is expected to be commissioned over the next three years
The company operates a chain of mid-sized multi-speciality hospitals
The new site marks the company’s first operation in the region
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
Subscribe To Our Newsletter & Stay Updated
